sulfabenzamide is an approved drug (FDA (1945))
Compound class:
Synthetic organic
Comment: Sulfabenzamide is a sulfonamide antibacterial compound. It inhibits the bacterial dihydropteroate synthase pathway which generates the folic acid that is essential for bacterial growth.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1945)) |
IUPAC Name |
N-(4-aminophenyl)sulfonylbenzamide |
International Nonproprietary Names | |
INN number | INN |
3177 | sulfabenzamide |
Database Links | |
Specialist databases | |
Antibiotic DB | Sulfabenzamide |
Other databases | |
CAS Registry No. | 127-71-9 (source: Scifinder) |
ChEBI | CHEBI:94677 |
ChEMBL Ligand | CHEMBL1243 |
DrugCentral Ligand | 3558 |
GtoPdb PubChem SID | 479821422 |
PubChem CID | 5319 |
RCSB PDB Ligand | BS4 |
Search Google for chemical match using the InChIKey | PBCZLFBEBARBBI-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | PBCZLFBEBARBBI |
Search PubMed clinical trials | sulfabenzamide |
Search PubMed titles | sulfabenzamide |
Search PubMed titles/abstracts | sulfabenzamide |
UniChem Compound Search for chemical match using the InChIKey | PBCZLFBEBARBBI-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | PBCZLFBEBARBBI-UHFFFAOYSA-N |